Can scalp electrodes reach deep brain areas to restore arm function after stroke?

NCT ID NCT07792811

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This study tests a new non-invasive brain stimulation method that targets deep brain structures through the scalp, without surgery, to improve arm and hand function in people who had a stroke at least 12 weeks ago. Participants receive either active stimulation or a sham version, combined with intensive physiotherapy three times a day for a week. Researchers measure changes in arm movement, daily activities, and brain function to see if the treatment is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Non-invasive transcranial Temporal Interference Stimulation (tTIS) targeting the striatum, delivered via scalp electrodes without surgery
What this could lead to
If effective, this approach could offer a non-invasive way to boost arm and hand recovery after stroke, potentially improving independence and quality of life for many survivors.
What could go wrong
The trial is in early-to-mid stages, and results may not show a clear benefit over sham stimulation. The intensive therapy schedule and individual brain differences could also affect outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Informed Consent signed by the participant 2. Age ≥ 18 years old 3. First ever ischemic stroke with motor impairment 4. Stroke incident ≥ 12 weeks at consent 5. Moderate to severe motor impairment (Fugl-Meyer Assessment (FMA) \>20 and \<58) Exclusion Criteria: 1. Unable to provide informed consent due to cognitive, psychiatric, or medical conditions impairing decision-making capacity 2. Severe neuropsychiatric (e.g., major depression, schizophrenia) or medical disease (e.g., progressive cancer, unstable systemic disease, neurodegenerative disease) 3. Severe cognitive, sensory or musculoskeletal dysfunctions prohibiting to understand instructions or to perform the rehabilitative tasks 4. Contraindications for NIBS or MRI a. Electronic or ferromagnetic medical implants/device, non-MRI compatible metal implant, b. Fully or partially implanted conductive objects i. Passive implants: stents, orthopedic/orthodontic implants, screws, shunts, etc. ii. Active implants: cochlear implants, deep brain stimulation leads and electrodes, fully implanted brain monitoring devices iii. Partially implanted devices: monitoring electrodes (e.g., stereoelectroencephalography, electrocortigraphy, etc. iv. Surface-mounted conductive objects: conductive low-impedance structure mounted to the skin that may introduce shortcuts. c. History of seizures d. Medication that significantly interacts with NIBS being benzodiazepines, tricyclic antidepressants and antipsychotics. e. Non-intact skin where electrodes are intended ot be placed 5. Pregnancy 6. Regular use of narcotic drugs or abusive alcohol consumption 7. Integral and bilateral lesion of the striatum 8. Concomittant participation in another clinical trial 9. Active request of not being informed in case of incidental findings

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ischemic stroke with motor impairment are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CRR SUVA

    Sion, Valais, 1951, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.